Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.40%
#4 aPriori aPriori +133.73%
#5 Bedrock Bedrock +69.96%
#6 Cysic Cysic +48.18%
#7 Prom Prom +40.32%
#8 Playnance Playnance +34.95%
#9 COTI COTI +27.64%
#10 Bitway Bitway +26.68%
Coin of the day
Wrapped One Wrapped One
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Classifica tra le azioni #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Prezzo delle azioni
$0.85
Ultima sincronizzazione: 2025-01-21
Capitalizzazione di mercato
$411.40
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Fresh2 Group Limited (FRES)

Categoria

Healthcare
Ricavi di Fresh2 Group Limited (FRES)
Ricavi nel Jun 2023 TTM: $1.64M
Secondo gli ultimi rapporti finanziari di Fresh2 Group Limited, i ricavi attuali dell'azienda (TTM) sono pari a $1.64M. Nel 2021, l'azienda ha registrato ricavi di $2.79M una diminuzione rispetto a i ricavi dell'anno 2020, che erano pari a $2.97M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Fresh2 Group Limited da 2017 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $1.64M -5.98%
2022 $1.75M -37.49%
2021 $2.79M -5.89%
2020 $2.97M 91.09%
2019 $1.55M 0.32%
2018 $1.55M 81.73%
2017 $851.95K 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 768,932.17%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 366,697.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 615,816.94%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR